Abramson Cancer Center; Univ of Pennsylvania; Clinical Research Unit — Philadelphia, Pennsylvania

Abramson Cancer Center; Univ of Pennsylvania; Clinical Research Unit is a clinical research site located in Philadelphia, Pennsylvania, United States 19106.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Abramson Cancer Center; Univ of Pennsylvania; Clinical Research Unit has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Breast Cancer.

Sponsors: Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Abramson Cancer Center; Univ of Pennsylvania; Clinical Research Unit?

Abramson Cancer Center; Univ of Pennsylvania; Clinical Research Unit has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Abramson Cancer Center; Univ of Pennsylvania; Clinical Research Unit conducted?

Abramson Cancer Center; Univ of Pennsylvania; Clinical Research Unit has 2 clinical trials on record, with 2 currently active. Their work covers Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Breast Cancer.

Is Abramson Cancer Center; Univ of Pennsylvania; Clinical Research Unit accredited by Crixeo Health?

Abramson Cancer Center; Univ of Pennsylvania; Clinical Research Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Abramson Cancer Center; Univ of Pennsylvania; Clinical Research Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.